356 related articles for article (PubMed ID: 29843450)
1. Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development.
Sgrignani J; Garofalo M; Matkovic M; Merulla J; Catapano CV; Cavalli A
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843450
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics exploration of PAK1 (P21-activated kinase-1) revealed potential network gene elements in breast invasive carcinoma.
Yellapu NK; Pulaganti M; Pakala SB
J Biomol Struct Dyn; 2017 Aug; 35(10):2269-2279. PubMed ID: 27456030
[TBL] [Abstract][Full Text] [Related]
3. Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo.
Huang W; Dong Z; Chen Y; Wang F; Wang CJ; Peng H; He Y; Hangoc G; Pollok K; Sandusky G; Fu XY; Broxmeyer HE; Zhang ZY; Liu JY; Zhang JT
Oncogene; 2016 Feb; 35(6):783-92. PubMed ID: 26073084
[TBL] [Abstract][Full Text] [Related]
4. Molecular Determinants for Unphosphorylated STAT3 Dimerization Determined by Integrative Modeling.
Sgrignani J; Olsson S; Ekonomiuk D; Genini D; Krause R; Catapano CV; Cavalli A
Biochemistry; 2015 Sep; 54(35):5489-501. PubMed ID: 26283080
[TBL] [Abstract][Full Text] [Related]
5. Strategies and Approaches of Targeting STAT3 for Cancer Treatment.
Furtek SL; Backos DS; Matheson CJ; Reigan P
ACS Chem Biol; 2016 Feb; 11(2):308-18. PubMed ID: 26730496
[TBL] [Abstract][Full Text] [Related]
6. Signal Transducer and Activator of Transcription Protein 3 (STAT3): An Update on its Direct Inhibitors as Promising Anticancer Agents.
Gelain A; Mori M; Meneghetti F; Villa S
Curr Med Chem; 2019; 26(27):5165-5206. PubMed ID: 30027840
[TBL] [Abstract][Full Text] [Related]
7. Consequences of the disease-related L78R mutation for dimerization and activity of STAT3.
Domoszlai T; Martincuks A; Fahrenkamp D; Schmitz-Van de Leur H; Küster A; Müller-Newen G
J Cell Sci; 2014 May; 127(Pt 9):1899-910. PubMed ID: 24569879
[TBL] [Abstract][Full Text] [Related]
8. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
Shin DS; Kim HN; Shin KD; Yoon YJ; Kim SJ; Han DC; Kwon BM
Cancer Res; 2009 Jan; 69(1):193-202. PubMed ID: 19118003
[TBL] [Abstract][Full Text] [Related]
9. STAT3 and metabolism: how many ways to use a single molecule?
Demaria M; Camporeale A; Poli V
Int J Cancer; 2014 Nov; 135(9):1997-2003. PubMed ID: 24500994
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel STAT3 small molecule inhibitors via in silico site-directed fragment-based drug design.
Yu W; Xiao H; Lin J; Li C
J Med Chem; 2013 Jun; 56(11):4402-12. PubMed ID: 23651330
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors of STAT3 for cancer therapy.
Zhao M; Jiang B; Gao FH
Curr Med Chem; 2011; 18(26):4012-8. PubMed ID: 21824090
[TBL] [Abstract][Full Text] [Related]
12. Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?
Huang Q; Zhong Y; Dong H; Zheng Q; Shi S; Zhu K; Qu X; Hu W; Zhang X; Wang Y
Eur J Med Chem; 2020 Feb; 187():111922. PubMed ID: 31810784
[TBL] [Abstract][Full Text] [Related]
13. Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation.
Dong J; Cheng XD; Zhang WD; Qin JJ
J Med Chem; 2021 Jul; 64(13):8884-8915. PubMed ID: 34170703
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy.
Masciocchi D; Gelain A; Villa S; Meneghetti F; Barlocco D
Future Med Chem; 2011 Apr; 3(5):567-97. PubMed ID: 21526897
[TBL] [Abstract][Full Text] [Related]
15. Cardamonin represses proliferation, invasion, and causes apoptosis through the modulation of signal transducer and activator of transcription 3 pathway in prostate cancer.
Zhang J; Sikka S; Siveen KS; Lee JH; Um JY; Kumar AP; Chinnathambi A; Alharbi SA; Basappa ; Rangappa KS; Sethi G; Ahn KS
Apoptosis; 2017 Jan; 22(1):158-168. PubMed ID: 27900636
[TBL] [Abstract][Full Text] [Related]
16. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.
Dourlat J; Liu WQ; Sancier F; Edmonds T; Pamonsinlapatham P; Cruzalegui F; Garbay C
Biochimie; 2009 Aug; 91(8):996-1002. PubMed ID: 19470402
[TBL] [Abstract][Full Text] [Related]
17. Dissecting functions of the N-terminal domain and GAS-site recognition in STAT3 nuclear trafficking.
Martincuks A; Fahrenkamp D; Haan S; Herrmann A; Küster A; Müller-Newen G
Cell Signal; 2016 Aug; 28(8):810-25. PubMed ID: 27040695
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the development of small molecular inhibitors that directly target the signal transducer and activator of transcription 3 (STAT3) domains.
Shih PC
Life Sci; 2020 Feb; 242():117241. PubMed ID: 31891719
[TBL] [Abstract][Full Text] [Related]
19. Electrochemical detection of the Fc-STAT3 phosphorylation and STAT3-Fc-STAT3 dimerization and inhibition.
Martic S; Rains MK; Haftchenary S; Shahani VM; Kraskouskaya D; Ball DP; Gunning PT; Kraatz HB
Mol Biosyst; 2014 Mar; 10(3):576-80. PubMed ID: 24402062
[TBL] [Abstract][Full Text] [Related]
20. The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy.
Tolomeo M; Cascio A
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
